Studies demonstrate that the Jetstream System is safe and effective in the treatment of infrainguinal arterial lesions, and effectively removes calcium in moderately and severely calcified lesions.

The Multicenter Pathway PVD Trial1

99% device success (208/210 lesions)1 ​ 1% MAE at 30 days (2 preplanned amputations)1​ ​ Calcium reduction resulted in a ​ 78% increase in lumen area [70, 86] 2​ ​ Minimum lumen area increased from 4.3​ [3.0, 5.5] mm2 to 7.4 [6.6, 10.3] mm2 (p<0.0001)2 99% device success (208/210 lesions)1 ​ 1% MAE at 30 days (2 preplanned amputations)1​ ​ Calcium reduction resulted in a ​ 78% increase in lumen area [70, 86] 2​ ​ Minimum lumen area increased from 4.3​ [3.0, 5.5] mm2 to 7.4 [6.6, 10.3] mm2 (p<0.0001)2
1% major adverse events at 30 days | 2 pre-planned amputations 1% major adverse events at 30 days | 2 pre-planned amputations